Publication

Autophagy in normal hematopoiesis and leukemia: Biological and therapeutic implications

Folkerts, H., 2019, [Groningen]: Rijksuniversiteit Groningen. 220 p.

Research output: ThesisThesis fully internal (DIV)Academic

Copy link to clipboard

Documents

  • Title and contents

    Final publisher's version, 113 KB, PDF-document

  • Chapter 1

    Final publisher's version, 818 KB, PDF-document

  • Chapter 2

    Final publisher's version, 7 MB, PDF-document

  • Chapter 3

    Final publisher's version, 7 MB, PDF-document

  • Chapter 4

    Final publisher's version, 3 MB, PDF-document

  • Chapter 5

    Final publisher's version, 7 MB, PDF-document

  • Chapter 6

    Final publisher's version, 5 MB, PDF-document

    Embargo ends: 25/03/2020

    Request copy

  • Chapter 7

    Final publisher's version, 2 MB, PDF-document

  • Complete thesis

    Final publisher's version, 27 MB, PDF-document

    Embargo ends: 25/03/2020

    Request copy

  • Propositions

    Final publisher's version, 549 KB, PDF-document

  • Hendrik Folkerts
All together the studies in this thesis show that autophagy is an essential survival mechanism for both normal hematopoietic and AML cells and MDS erythroblasts. Altered expression of autophagy-associated genes might have consequences for drug resistance. Therefore, these findings suggest that inhibition of autophagy might be a promising therapeutic strategy for the treatment of AML.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
Supervisors/Advisors
  • Vellenga, Edo, Supervisor
  • Schuringa, Jan Jacob, Supervisor
  • Coffer, Paul J., Supervisor, External person
  • Touw, I.P., Assessment committee, External person
  • Kampinga, Harm, Assessment committee
  • den Berg, J.H.M.van, Assessment committee, External person
Award date25-Mar-2019
Place of Publication[Groningen]
Publisher
Print ISBNs978-94-6375-301-2
Publication statusPublished - 2019

View graph of relations

Download statistics

No data available

ID: 77299264